SCRI - HCA Midwest Division — Kansas City, Kansas

SCRI - HCA Midwest Division is a clinical research site located in Kansas City, Kansas, United States 61432.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI - HCA Midwest Division has participated in 1 clinical trials.

Therapeutic areas: Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Sponsors: Innocrin Pharmaceutical.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Kansas · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - HCA Midwest Division?

SCRI - HCA Midwest Division has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - HCA Midwest Division conducted?

SCRI - HCA Midwest Division has 1 clinical trials on record. Their work covers Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Is SCRI - HCA Midwest Division accredited by Crixeo Clinical Trials?

SCRI - HCA Midwest Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - HCA Midwest Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.